dalteparin has been researched along with Postthrombotic Syndrome in 9 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Postthrombotic Syndrome: A condition caused by one or more episodes of DEEP VEIN THROMBOSIS, usually the blood clots are lodged in the legs. Clinical features include EDEMA; PAIN; aching; heaviness; and MUSCLE CRAMP in the leg. When severe leg swelling leads to skin breakdown, it is called venous STASIS ULCER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated the effect of long-term anticoagulant treatment (enoxaparin vs coumarin) in patients with deep venous thrombosis (DVT) as to incidence of post-thrombotic syndrome (PTS) and recurrent venous thromboembolism." | 9.13 | Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin. ( Castrodeza, J; González-Fajardo, JA; Martin-Pedrosa, M; Tamames, S; Vaquero-Puerta, C, 2008) |
| "Rivaroxaban treatment was associated with a lower risk of PTS when compared to enoxaparin/warfarin; RVT however, was not a mediator in the association between PTS and type of treatment." | 5.56 | Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban. ( Annichino-Bizzacchi, JM; Bittar, LF; Colella, MP; de Moraes Martinelli, B; de Oliveira, LFG; de Paula, EV; Ferreira, T; Huber, SC; Junior, AL; Mello, TT; Menezes, FH; Montalvão, S; Orsi, FA; Rielli, G; Sodre, LR; Yamaguti-Hayakawa, GG, 2020) |
| "We evaluated the effect of long-term anticoagulant treatment (enoxaparin vs coumarin) in patients with deep venous thrombosis (DVT) as to incidence of post-thrombotic syndrome (PTS) and recurrent venous thromboembolism." | 5.13 | Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin. ( Castrodeza, J; González-Fajardo, JA; Martin-Pedrosa, M; Tamames, S; Vaquero-Puerta, C, 2008) |
| "Patients with iliac deep vein thrombosis (DVT) have a poor prognosis and high incidence of postthrombotic syndrome (PTS)." | 2.78 | Effect of long-term LMWH on post-thrombotic syndrome in patients with iliac/noniliac venous thrombosis: a subanalysis from the home-LITE study. ( Hull, RD; Liang, J; Merali, T, 2013) |
| "Rivaroxaban treatment was associated with a lower risk of PTS when compared to enoxaparin/warfarin; RVT however, was not a mediator in the association between PTS and type of treatment." | 1.56 | Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban. ( Annichino-Bizzacchi, JM; Bittar, LF; Colella, MP; de Moraes Martinelli, B; de Oliveira, LFG; de Paula, EV; Ferreira, T; Huber, SC; Junior, AL; Mello, TT; Menezes, FH; Montalvão, S; Orsi, FA; Rielli, G; Sodre, LR; Yamaguti-Hayakawa, GG, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hull, RD | 3 |
| Liang, J | 3 |
| Townshend, G | 1 |
| Baumann Kreuziger, L | 1 |
| Feng, M | 1 |
| Bartosic, A | 1 |
| Simpson, P | 1 |
| Wang, TF | 1 |
| Ferreira, T | 1 |
| Huber, SC | 1 |
| de Moraes Martinelli, B | 1 |
| Junior, AL | 1 |
| Menezes, FH | 1 |
| Orsi, FA | 1 |
| Bittar, LF | 1 |
| de Oliveira, LFG | 1 |
| Sodre, LR | 1 |
| Mello, TT | 1 |
| Rielli, G | 1 |
| Colella, MP | 1 |
| de Paula, EV | 1 |
| Yamaguti-Hayakawa, GG | 1 |
| Montalvão, S | 1 |
| Annichino-Bizzacchi, JM | 1 |
| Cheung, YW | 1 |
| Middeldorp, S | 1 |
| Prins, MH | 1 |
| Pap, AF | 1 |
| Lensing, AW | 1 |
| Ten Cate-Hoek, AJ | 1 |
| Villalta, S | 1 |
| Milan, M | 1 |
| Beyer-Westendorf, J | 1 |
| Verhamme, P | 1 |
| Bauersachs, RM | 1 |
| Prandoni, P | 1 |
| González-Fajardo, JA | 1 |
| Martin-Pedrosa, M | 1 |
| Castrodeza, J | 1 |
| Tamames, S | 1 |
| Vaquero-Puerta, C | 1 |
| Reich-Schupke, S | 1 |
| Doerler, M | 1 |
| Altmeyer, P | 1 |
| Stücker, M | 1 |
| Makedonov, I | 1 |
| Kahn, S | 1 |
| Abdulrehman, J | 1 |
| Schulman, S | 1 |
| Delluc, A | 1 |
| Gross, PL | 1 |
| Galanaud, JP | 1 |
| Merali, T | 1 |
| Pineo, GF | 1 |
| Brant, R | 1 |
| Cook, R | 1 |
| Solymoss, S | 1 |
| Poon, MC | 1 |
| Raskob, G | 1 |
1 review available for dalteparin and Postthrombotic Syndrome
| Article | Year |
|---|---|
Long-term low-molecular-weight heparin and the post-thrombotic syndrome: a systematic review.
Topics: Anticoagulants; Dalteparin; Drug Administration Schedule; Enoxaparin; Heparin, Low-Molecular-Weight; | 2011 |
5 trials available for dalteparin and Postthrombotic Syndrome
| Article | Year |
|---|---|
Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis.
Topics: Adult; Aged; Anticoagulants; Enoxaparin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Postt | 2016 |
Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin.
Topics: Anticoagulants; Coumarins; Enoxaparin; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Ag | 2008 |
TILE pilot trial study protocol: Tinzaparin Lead-in to Prevent the Post-Thrombotic syndrome study protocol.
Topics: Anticoagulants; Humans; Pilot Projects; Postthrombotic Syndrome; Quality of Life; Randomized Control | 2023 |
Effect of long-term LMWH on post-thrombotic syndrome in patients with iliac/noniliac venous thrombosis: a subanalysis from the home-LITE study.
Topics: Cohort Studies; Drug Administration Schedule; Female; Fibrinolytic Agents; Heparin, Low-Molecular-We | 2013 |
Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome.
Topics: Administration, Oral; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Home Care Services | 2009 |
3 other studies available for dalteparin and Postthrombotic Syndrome
| Article | Year |
|---|---|
A prospective cohort study of catheter-related thrombosis in cancer patients treated with 1 month of anticoagulation after catheter removal.
Topics: Anticoagulants; Catheters; Enoxaparin; Hemorrhage; Humans; Neoplasms; Pilot Projects; Postthrombotic | 2022 |
Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban.
Topics: Adult; Anticoagulants; Brazil; Cross-Sectional Studies; Enoxaparin; Factor Xa Inhibitors; Female; Hu | 2020 |
Foam sclerotherapy with enoxaparin prophylaxis in high-risk patients with postthrombotic syndrome.
Topics: Anticoagulants; Combined Modality Therapy; Drug Administration Schedule; Enoxaparin; Humans; Polidoc | 2013 |